Knowledge Hub

Vaccine-preventable diarrhea is linked to poor growth

A prospective case-control study conducted in several developing countries found that children with moderate-to-severe diarrhea grew significantly less in length in the two months following their episode compared to age- and gender-matched controls.

Full Citation:
Kotloff, K.L., Nataro, J.P., Blackwelder, W.C., et al. 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 382(9888).

Title of Article: Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

Author(s): Kotloff, K.L., Nataro, J.P., Blackwelder, W.C., et al

Publication Year: 2013

Publication Name: Lancet

Publication Volume: 382(9888)

Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/23680352/

DOI (Digital Object Identifier): 10.1016/S0140-6736(13)60844-2

Topics: Health

Disease Vaccines: Diarrhea

Countries: Bangladesh | Gambia | India | Kenya | Mali | Mozambique | Pakistan

WHO Regions: Africa | Eastern Mediterranean | South-East Asia